These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Rheingans R; Atherly D; Anderson J Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124 [TBL] [Abstract][Full Text] [Related]
4. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries. Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590 [TBL] [Abstract][Full Text] [Related]
5. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan. Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600 [TBL] [Abstract][Full Text] [Related]
6. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand. Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220 [TBL] [Abstract][Full Text] [Related]
7. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana. Abbott C; Tiede B; Armah G; Mahmoud A Vaccine; 2012 Mar; 30(15):2582-7. PubMed ID: 22321664 [TBL] [Abstract][Full Text] [Related]
9. Projected cost-effectiveness of rotavirus vaccination for children in Asia. Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of rotavirus vaccination in Argentina. Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ; Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149 [TBL] [Abstract][Full Text] [Related]
12. Health and economic impact of rotavirus vaccination in GAVI-eligible countries. Kim SY; Sweet S; Slichter D; Goldie SJ BMC Public Health; 2010 May; 10():253. PubMed ID: 20470426 [TBL] [Abstract][Full Text] [Related]
13. Epidemiological and Economic Impact of Monovalent and Pentavalent Rotavirus Vaccines in Low and Middle Income Countries: A Cost-effectiveness Modeling Analysis. Paternina-Caicedo A; De la Hoz-Restrepo F; Alvis-Guzmán N Pediatr Infect Dis J; 2015 Jul; 34(7):e176-84. PubMed ID: 25923424 [TBL] [Abstract][Full Text] [Related]
14. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria. Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927 [TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of rotavirus vaccination in Armenia. Jit M; Yuzbashyan R; Sahakyan G; Avagyan T; Mosina L Vaccine; 2011 Nov; 29(48):9104-11. PubMed ID: 21945959 [TBL] [Abstract][Full Text] [Related]
16. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China. Liu N; Yen C; Fang ZY; Tate JE; Jiang B; Parashar UD; Zeng G; Duan ZJ Vaccine; 2012 Nov; 30(48):6940-5. PubMed ID: 22705174 [TBL] [Abstract][Full Text] [Related]
17. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study. Debellut F; Clark A; Pecenka C; Tate J; Baral R; Sanderson C; Parashar U; Kallen L; Atherly D Lancet Glob Health; 2019 Dec; 7(12):e1664-e1674. PubMed ID: 31708147 [TBL] [Abstract][Full Text] [Related]
18. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595 [TBL] [Abstract][Full Text] [Related]
19. Economic evaluations of rotavirus immunization for developing countries: a review of the literature. Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model. Patel HD; Roberts ET; Constenla DO Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]